ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
1 story in the last 7 days
The latest s&p news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks s&p across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
Moody's and S&P assigned investment-grade ratings to Sun Pharmaceutical Industries for its proposed USD 11.75-billion acquisition of US-based Organon & Co. S&P gave a 'BBB+' rating, Moody's a 'Baa1', both with a 'stable' outlook.
Summaries by ByteBrief